Increasing daily steps through tailored communication
Efficacy of a Tailored Communication Intervention Aimed At Increasing the Number of Daily Steps
This study is testing whether a mobile app that sends personalized messages can help inactive adults walk more and reach a daily goal of 7,000 steps.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 255 (estimated) |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Sponsor | University of Milano Bicocca Academic / other |
| Locations | 1 site (Milan, MI) |
| Trial ID | NCT05620888 on ClinicalTrials.gov |
What this trial studies
This intervention evaluates the effectiveness of a mobile app designed to promote walking behavior among sedentary adults. Over 30 days, participants will receive either tailored or non-tailored messages aimed at increasing their daily step count to 7,000 steps. The study will assess changes in attitudes, self-efficacy, and social support before and after the intervention, comparing the physical activity levels of those receiving messages to a control group. The goal is to determine which type of communication is more effective in fostering behavior change.
Who should consider this trial
Good fit: Ideal candidates are healthy, sedentary adults who own a smartphone and are willing to engage in a 30-day walking program.
Not a fit: Patients who are already active, taking at least 7,000 steps daily, or have medical conditions that restrict physical activity may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance physical activity levels among sedentary individuals, improving overall health outcomes.
How similar studies have performed: Previous studies have shown that tailored communication can effectively promote behavior change, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Participants from the general population, in good health and sedentary * A level of education sufficient to understand the procedures of the study and to use a smartphone * Having a smartphone Exclusion Criteria: * The participant always (or almost always) takes at least 7,000 steps a day * The participant achieves an IPAQ score equal to or greater than 3000 MET-min / week * The participant has symptoms or pathologies that could represent a contraindication to the physical activity proposed by the study. In particular * Cardiovascular diseases for which physical activity is allowed only under medical supervision * Chest pain during daily activities * Drug treatment for cardiovascular diseases * Severe arterial hypertension not pharmacologically controlled * Episodes of loss of consciousness within the past 12 months * Osteoarticular disorders that could be aggravated by a change in the level of physical activity * Fractures of the lower limbs, vertebrae, or pelvis in the past six months * Walking difficulty * Respiratory insufficiency
Where this trial is running
Milan, MI
- University of Milano-Bicocca — Milan, Mi, Italy (Recruiting)
Study contacts
- Principal investigator: Marco D'Addario, PhD — University of Milano Bicocca
- Study coordinator: Marco D'Addario, PhD
- Email: marco.daddario@unimib.it
- Phone: 0039 02 6448 3824
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.